A
NYSE · Life Sciences Tools & Services
Agilent Technologies Inc
$113.98
+1.97 (+1.76%)
Financial Highlights (FY 2026)
Revenue
6.90B
Net Income
1.29B
Gross Margin
52.7%
Profit Margin
18.8%
Rev Growth
+0.5%
D/E Ratio
0.50
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 52.7% | 52.7% | 40.1% | 40.1% |
| Operating Margin | 21.5% | 19.3% | 23.7% | 19.8% |
| Profit Margin | 18.8% | 17.8% | 15.6% | 18.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 6.90B | 6.86B | 8.58B | 10.41B |
| Gross Profit | 3.64B | 3.62B | 3.44B | 4.17B |
| Operating Income | 1.48B | 1.33B | 2.03B | 2.07B |
| Net Income | 1.29B | 1.16B | 1.34B | 1.96B |
| Gross Margin | 52.7% | 52.7% | 40.1% | 40.1% |
| Operating Margin | 21.5% | 19.3% | 23.7% | 19.8% |
| Profit Margin | 18.8% | 17.8% | 15.6% | 18.8% |
| Rev Growth | +0.5% | +0.5% | +1.4% | -2.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 5.18B | 5.18B | 17.11B | 16.12B |
| Total Equity | 10.41B | 10.41B | 25.55B | 26.65B |
| D/E Ratio | 0.50 | 0.50 | 0.67 | 0.60 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 1.80B | 1.70B | 2.68B | 2.92B |
| Free Cash Flow | — | — | 652.76M | 1.31B |